BioCryst Pharmaceuticals, Inc.
| Article | Date | Source |
|---|
| Biocryst Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results | May 07, 2013 | BioSpace - Breaking News |
| Could a smaller BioCryst pharma be more effective? | May 07, 2013 | Health News - BizJournals.com |
| BioCryst Provides Corporate Update and Reports First Quarter 2013 Financial Results | May 07, 2013 | Biotech News - Business Wire |
| BioCryst Provides Corporate Update and Reports First Quarter 2013 Financial Results | May 07, 2013 | Pharma News - Business Wire |
| BioCryst to Announce First Quarter 2013 Financial Results May 7 | April 23, 2013 | Pharma News - PharmiWeb |
| BioCryst to Announce First Quarter 2013 Financial Results May 7 | April 23, 2013 | Pharma News - Business Wire |
| BioCryst launches Phase 1 trial for HAE candidate | March 26, 2013 | Health News - BizJournals.com |
| BioCryst launches Phase 1 trial for HAE candidate | March 25, 2013 | Health News - BizJournals.com |
| BioCryst stock downgraded again | February 11, 2013 | Health News - BizJournals.com |
| BofA resumes research coverage of BioCryst Pharma | February 05, 2013 | Health News - BizJournals.com |
| Troubled BioCryst dumps HCV preclinical program | January 29, 2013 | FierceBiotech Research |
| Biocryst Pharmaceuticals Sweetens Pot for Employees | January 08, 2013 | BioSpace |
| BioCryst sweetens pot for employees | January 08, 2013 | Health News - BizJournals.com |
| Revenue rises at BioCryst Pharmaceuticals | August 02, 2012 | Health News - BizJournals.com |
| BioCryst Provides Corporate Update and Reports Second Quarter 2012 Financial Results | August 02, 2012 | FDA News - Business Wire |
| BioCryst gets good news on gout treatment | July 24, 2012 | Health News - BizJournals.com |
| Biocryst Pharmaceuticals Reveals Favorable Results From Ulodesine In Phase II Clinical Trials | July 24, 2012 | BioSpace |
| BioCryst Announces Positive Results from Two Ulodesine Phase 2 Trials in Patients with Gout | July 24, 2012 | FDA News - Business Wire |
| BioCryst to Report Second Quarter 2012 Financial Results on August 2, 2012 | July 19, 2012 | FDA News - Business Wire |
| BioCryst to Present at the 7th Annual JMP Securities Healthcare Conference | June 28, 2012 | FDA News - Business Wire |
| BioCryst Presents Results from Its BCX4208 Gout Program at the Annual European Congress of Rheumatology | June 06, 2012 | FDA News - Business Wire |
| BioCryst revenue more than doubles in 1Q | May 07, 2012 | Health News - BizJournals.com |
| BioCryst Provides Corporate Update and Reports First Quarter 2012 Financial Results | May 07, 2012 | Pharma News - Business Wire |
| BioCryst to Report First Quarter 2012 Financial Results on May 7, 2012 | April 25, 2012 | FDA News - Business Wire |
| BioCryst net loss increases to $13.2M | February 16, 2012 | Health News - BizJournals.com |
| Biocryst Pharmaceuticals Announces Promising Results from Preclinical Studies of BCX5191 for Hepatitis C | February 15, 2012 | BioSpace |
| BioCryst pleased with preclinical results | February 15, 2012 | Health News - BizJournals.com |
| BioCryst Announces Promising Results from Preclinical Studies of BCX5191 for Hepatitis C | February 15, 2012 | Pharma News - Business Wire |
| BioCryst to Announce Fourth Quarter and Full Year 2011 Financial Results on February 16, 2012 | February 06, 2012 | Pharma News - Business Wire |
| Nancy Hutson Appointed to Biocryst Pharmaceuticals (BCRX)âs Board of Directors | January 19, 2012 | Pharmaceutical - Moreover |
| <b>Nancy Hutson</b> Appointed toBiocryst Pharmaceuticals???s Board of Directors | January 19, 2012 | BioSpace - Breaking News |
| Biocryst Pharmaceuticals Announces Positive Results from Its Ongoing BCX4208 Phase 2B Study in Patients With Gout | January 09, 2012 | BioSpace |
| BioCryst gets good news on drug trial | January 09, 2012 | Health News - BizJournals.com |
| Biocryst Pharmaceuticals Experimental Gout Drug Helps Patients in Trial | November 09, 2011 | BioSpace |
| BioCryst Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2011 Financial Results | November 02, 2011 | Pharma News - PharmiWeb |
| Biocryst Pharmaceuticals Announces New BCX4208 Gout Data Has Been Accepted as a Late-Breaker Oral Presentation at the
| October 24, 2011 | BioSpace - Breaking News |
| BioCryst Pharmaceuticals Announces New BCX4208 Gout Data Has Been Accepted as a Late-Breaker Oral Presentation at the ACR/ARHP 2011 Annual Scientific Meeting | October 24, 2011 | Pharma News - Business Wire |
| BioCryst Pharmaceuticals to Announce Third Quarter 2011 Financial Results on November 2, 2011 | October 19, 2011 | Pharma News - Business Wire |
| Biocryst Pharmaceuticals Appoints George B. Abercrombie to Board | October 11, 2011 | Pharmaceutical - Moreover |
| BioCryst (BCRX) Elects George Abercrombie to Board | October 11, 2011 | Pharmaceutical - Moreover |
| BIOCRYST PHARMACEUTICALS, INC.: Biocryst Pharmaceuticals Announces Changes to I.. | October 11, 2011 | Pharmaceutical - Moreover |
| BioCryst Pharmaceuticals gets good news on drug | October 05, 2011 | Health News - BizJournals.com |
| Biocryst Pharmaceuticals Shares Rise; Phase 2b Study Of Add-on Gout Therapy BCX2408 Meets Primary Endpoint
| October 05, 2011 | BioSpace |
| Biocryst Pharmaceuticals Announces Positive Top-Line Results from BCX4208 Phase 2B Gout Study in Patients Not Responding to Allopurinol Alone
| October 05, 2011 | BioSpace |
| BioCryst shares surge on positive IIb study for gout drug | October 05, 2011 | FierceBiotech |
| BioCryst says gout drug worked in mid-stage trial | October 05, 2011 | Health News - CNBC |
| BioCryst Announces Positive Top-Line Results from BCX4208 Phase 2B Gout Study in Patients Not Responding to Allopurinol Alone | October 05, 2011 | Pharma News - Business Wire |
| BioCryst To Present New Peramivir Data at the 51st Annual ICAAC Meeting | September 17, 2011 | Pharma News - Business Wire |
| BioCryst to Present at Three Upcoming Investor Conferences | September 06, 2011 | Pharma News - Business Wire |
| Biocryst Pharmaceuticals (BCRX) Provides Corporate Update and Reports Second Quarter | August 05, 2011 | Biotechnology - Moreover |
| BioCryst takes bigger loss on lower gov't funding | August 04, 2011 | Health News - CNBC |
| CORRECTING and REPLACING BioCryst Provides Corporate Update and Reports Second Quarter 2011 Financial Results | August 04, 2011 | FDA News - Business Wire |
| BioCryst Provides Corporate Update and Reports Second Quarter 2011 Financial Results | August 04, 2011 | FDA News - Business Wire |
| Biocryst Pharmaceuticals (BCRX) to Announce Second Quarter 2011 Financial Results on August 4, 20 | July 26, 2011 | Biotechnology - Moreover |
| BioCryst Pharmaceuticals to Announce Second Quarter 2011 Financial Results on August 4, 2011 | July 26, 2011 | Pharma News - Business Wire |
| BioCryst reaches deal with McNicoll, Lewis & Vlak to market shares | July 05, 2011 | Health News - BizJournals.com |
| BioCryst files for $70M shelf offering | June 29, 2011 | Health News - BizJournals.com |
| Hatteras’ Ken Lee joins BioCryst board | June 27, 2011 | Health News - BizJournals.com |
| BioCryst Pharma elects Kenneth Lee to board | June 27, 2011 | Health News - CNBC |
| Kenneth Lee Appointed to BioCryst Pharmaceuticals’ Board of Directors | June 27, 2011 | Pharma News - Business Wire |
| Drug stocks climb as BioCryst rallies | June 13, 2011 | Biotechnology - Moreover |
| Drug stocks mixed as BioCryst rallies | June 13, 2011 | Biotechnology - Moreover |
| Biocryst Pharmaceuticals (BCRX) Presents New Analyses of BCX42 | May 27, 2011 | Biotechnology - Moreover |
| Biocryst Pharmaceuticals Presents New Analyses of BCX4208 Phase 2 Studies in Patients with Gout at the Annual | May 26, 2011 | BioSpace - Breaking News |
| BioCryst Presents New Analyses of BCX4208 Phase 2 Studies in Patients with Gout at the Annual European Congress of Rheumatology | May 26, 2011 | FDA News - Business Wire |
| BioCryst appoints pharma veteran as new CFO | May 25, 2011 | Health News - CNBC |
| BioCryst Pharmaceuticals Announces Appointment of Thomas Staab as Its Next Chief Financial Officer | May 25, 2011 | FDA News - Business Wire |
| Biocryst Pharmaceuticals (BCRX) Provides Corporate Update and Reports First Quarter | May 05, 2011 | Biotechnology - Moreover |
| BioCryst Pharmaceuticals misses Street targets with 1Q loss, revenue | May 04, 2011 | Health News - BizJournals.com |
| BioCryst 1Q loss widens on revenue dip | May 04, 2011 | Health News - CNBC |
| BioCryst Provides Corporate Update and Reports First Quarter 2011 Financial Results | May 04, 2011 | FDA News - Business Wire |
| BioCryst to Present at Bank of America Merrill Lynch Healthcare Conference | May 03, 2011 | Pharma News - Business Wire |
| BioCryst Pharmaceuticals Announces Changes to Its Board of Directors | May 03, 2011 | FDA News - Business Wire |
| Biocryst Pharmaceuticals (BCRX) to Announce First Quarter 2011 Financial Results on May 4, 20 | April 26, 2011 | Biotechnology - Moreover |
| BioCryst Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 4, 2011 | April 25, 2011 | Pharma News - Business Wire |
| Biocryst Pharmaceuticals (BCRX) to Present New BCX42 | April 22, 2011 | Biotechnology - Moreover |
| BioCryst to Present New BCX4208 Gout Results at the Annual European Congress of Rheumatology | April 22, 2011 | FDA News - Business Wire |
| BioCryst Closes $30M Financing Deal for Clinical Development of Gout Treatment | March 10, 2011 | Inside Industry - Gen |
| Biocryst Pharmaceuticals Announces Close of $30 Million Financing Transaction Related to Future RAPIACTA(R) Payments | March 10, 2011 | BioSpace |
| BioCryst closes on $30M financing deal | March 09, 2011 | Health News - BizJournals.com |
| BioCryst Announces Close of $30 Million Financing Transaction Related to Future RAPIACTA® Payments | March 09, 2011 | FDA News - Business Wire |
| BioCryst awarded $55M contract modification | February 25, 2011 | Health News - BizJournals.com |
| HHS hands BioCryst $55M for Phase III trial | February 25, 2011 | FierceBiotech |
| Feds award BioCryst $55M more for work on flu treatment peramivir | February 25, 2011 | Health News - BizJournals.com |
| Biocryst Pharmaceuticals Awarded Additional $55.0 Million by the Department of Health and Human Services to Complete Peramivir Phase 3 Program | February 25, 2011 | BioSpace - Breaking News |
| BioCryst Awarded Additional $55.0 Million by the U.S. Department of Health & Human Services to Complete Peramivir Phase 3 Program | February 24, 2011 | FDA News - Business Wire |
| BioCryst Pharmaceuticals director stepping down | February 18, 2011 | Health News - BizJournals.com |
| BioCryst Shares Climb On Drug Update | February 11, 2011 | Health News - Fox Business |
| BioCryst reports 4Q loss on revenue dip | February 10, 2011 | Health News - CNBC |
| Biocryst Pharmaceuticals (BCRX) Provides Corporate Update and Reports Fourth Quarter and Full Year 20 | February 10, 2011 | Biotechnology - Moreover |
| BioCryst Provides Corporate Update and Reports Fourth Quarter and Full Year 2010 Financial Results | February 10, 2011 | Pharma News - Business Wire |
| Biocryst Pharmaceuticals (BCRX) to Announce Fourth Quarter and Full Year 2010 Financial Results on February 10, | February 04, 2011 | Biotechnology - Moreover |
| BioCryst Pharmaceuticals to Announce Fourth Quarter and Full Year 2010 Financial Results on February 10, 2011 | February 02, 2011 | FDA News - Business Wire |
| BioCryst shares slide on peramivir trial revisions | January 14, 2011 | FierceBiotech |
| Biocryst Pharmaceuticals Asks for Extension on Phase 3 Study | January 14, 2011 | BioSpace |
| BioCryst wants to extend IV flu drug study | January 13, 2011 | Health News - CNBC |
| Biocryst Pharmaceuticals Announces Peramivir Phase 3 Safety & Virology Study Results and Provides a Clinical Program Update | January 13, 2011 | BioSpace - Breaking News |
| Options Brief: BioCryst Pharmaceuticals (BCRX) | January 13, 2011 | Biotechnology - Moreover |
| BioCryst Falls On Study Delay For Flu Drug | January 13, 2011 | Health News - Fox Business |
| BioCryst Announces Peramivir Phase 3 Safety & Virology Study Results and Provides a Clinical Program Update | January 13, 2011 | FDA News - Business Wire |
| Biocryst Pharmaceuticals Initiates a Phase 2b Study of BCX4208 as Add-on Therapy in Gout Patients Not Responding to Allopurinol Alone | December 22, 2010 | BioSpace - Breaking News |
| BioCryst Initiates a Phase 2b Study of BCX4208 as Add-on Therapy in Gout Patients Not Responding to Allopurinol Alone | December 22, 2010 | Pharma News - Business Wire |
| BioCryst Reports New Data from Its Phase 2 Forodesine Study in Patients with Chronic Lymphocytic Leukemia at the 52nd Annual American Society of Hematology Meeting | December 04, 2010 | FDA News - Business Wire |
| BioCryst to Present New Data for BCX4208 Monotherapy at the 74th Annual American College of Rheumatology (ACR) Scientific Meeting | November 08, 2010 | Pharma News - Business Wire |
| BioCryst Awarded $1.1 Million in Grants for Qualifying Therapeutic Development Projects | November 02, 2010 | FDA News - Business Wire |
| BioCryst Reports Third Quarter 2010 Financial Results and Provides Corporate Update | October 28, 2010 | FDA News - Business Wire |
| Biocryst Pharmaceuticals's Partner Shionogi & Co., Ltd. Receives Approval for Pediatric Use Of Flu Drug Peramivir in Japan | October 27, 2010 | BioSpace - Breaking News |
| BioCryst partner gets flu treatment OK in Japan | October 27, 2010 | Health News - CNBC |
| BioCryst to Present at Oppenheimer Healthcare Conference | October 25, 2010 | Biotech News - Business Wire |
| BioCryst to Present New Clinical & Virologic Data for I.V. Peramivir at the 48th Annual IDSA Meeting | October 21, 2010 | Pharma News - Business Wire |
| BioCryst Ranked Number Five in Deloitte’s 2010 Technology Fast 500™ Program for Fastest Growing Companies in North America | October 20, 2010 | Pharma News - Business Wire |
| Biocryst Pharmaceuticals to Relocate Headquarters to Durham; Eliminating Eight Jobs | October 14, 2010 | BioSpace |
| Southern Research Expands Capabilities with Acquisition of BioCryst Pharmaceuticals Bioanalytical Lab Unit | October 14, 2010 | Clinical Trials - PR Newswire |
| BioCryst shifts HQ to Durham as it ramps up commercial ops | October 14, 2010 | FierceBiotech |
| BioCryst Pharmaceuticals moving HQ to Durham | October 14, 2010 | Health News - BizJournals.com |
| BioCryst to Present At JMP Securities Healthcare Conference | September 21, 2010 | Pharma News - Business Wire |
| BioCryst Announces Positive Results of Potential Gout Treatment | September 16, 2010 | Health News - Fox Business |
| Analysts: Weak PhIII cancer data hurts BioCryst's chances at FDA | September 16, 2010 | FierceBiotech |
| BioCryst Reports Positive Results From A Phase 2 Study Of BCX4208 Combined with Allopurinol in Patients with Gout | September 16, 2010 | FDA News - Business Wire |
| Biocryst Pharmaceuticals Reports Results from Two Forodesine Oncology Studies | September 15, 2010 | BioSpace - Breaking News |
| BioCryst to Present Peramivir Data at the 50th Annual ICAAC Meeting | September 15, 2010 | FDA News - Business Wire |
| BioCryst Reports Results from Two Forodesine Oncology Studies | September 15, 2010 | FDA News - Business Wire |
| BioCryst to Host & Webcast Investor Day on September 16, 2010 | September 08, 2010 | Pharma News - Business Wire |
| Biocryst Pharmaceuticals Partner Green Cross Receives Marketing & Manufacturing Approval for Peramivir in South Korea | August 16, 2010 | BioSpace - Breaking News |
| BioCryst flu drug wins approval for use in Korea | August 16, 2010 | Health News - BizJournals.com |
| BioCryst reports $10M net loss in 2Q | August 05, 2010 | Health News - BizJournals.com |
| BioCryst Reports Second Quarter 2010 Financial Results and Provides Corporate Update | August 05, 2010 | Pharma News - Business Wire |
| BioCryst Pharmaceuticals to Announce Second Quarter 2010 Financial Results on August 5, 2010 | July 27, 2010 | Pharma News - Business Wire |
| BioCryst Initiates a Phase 2 Study of BCX4208 Alone and in Combination with Allopurinol in Patients with Gout | June 01, 2010 | Pharma News - Business Wire |
| BioCryst to Present at Jefferies 2010 Global Life Sciences Conference | May 27, 2010 | Pharma News - Business Wire |
| BioCryst To Present at Two Upcoming Investor Conferences | May 03, 2010 | Pharma News - Business Wire |
| BioCryst stock jumps 13% Wednesday | April 28, 2010 | Health News - BizJournals.com |
| BioCryst rallies on gout study; AMAG falls | April 28, 2010 | Biotechnology - Moreover |
| BioCryst narrows 1Q net loss to $2.6M | April 28, 2010 | Health News - BizJournals.com |
| BioCryst gout drug meets goal in midstage study | April 28, 2010 | Health News - CNBC |
| BioCryst shares surge on positive PhIIa gout data | April 28, 2010 | FierceBiotech |
| BioCryst 1Q loss narrows on peramivir revenue | April 28, 2010 | Health News - CNBC |
| BioCryst Rallies On Gout Study; Indices Diverge | April 28, 2010 | Health News - Fox Business |
| Biocryst Pharmaceuticals Says Gout Drug Shows Positive Results | April 28, 2010 | BioSpace |
| BioCryst Reports First Quarter 2010 Financial Results and Provides Corporate Update | April 28, 2010 | Pharma News - Business Wire |
| BioCryst Reports Positive Results from Part One of Its Phase 2a Study of BCX4208 in Patients with Gout | April 28, 2010 | Biotech News - Business Wire |
| Company Profile for BioCryst Pharmaceuticals | April 23, 2010 | Pharma News - Business Wire |
| BioCryst Pharmaceuticals to Announce First Quarter 2010 Financial Results on April 28, 2010 | April 21, 2010 | Pharma News - Business Wire |
| BioCryst CEO Stonehouse's compensation rose 24% in '09 | April 07, 2010 | Health News - BizJournals.com |
| BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update | February 04, 2010 | Pharma News - PR Newswire |
| BioCryst To Present At 12th Annual BIO CEO & Investor Conference | February 01, 2010 | Medical Pharma - PR Newswire |
| BioCryst says Japan partner will launch flu drug | January 26, 2010 | Health News - CNBC |
| BioCryst's Partner Shionogi Launches Peramivir In Japan Under The Name 'RAPIACTA' | January 26, 2010 | Pharma News - PR Newswire |
| BioCryst Pharmaceuticals to Announce Fourth Quarter 2009 Financial Results on February 4, 2010 | January 21, 2010 | Pharma News - PR Newswire |
| Biocryst Pharmaceuticals's CTCL Pivotal Study Achieves Enrollment Target | January 15, 2010 | BioSpace - Breaking News |
| BioCryst's CTCL Pivotal Study Achieves Enrollment Target | January 15, 2010 | Clinical Trials - PR Newswire |
| Biocryst Pharmaceuticals's Partner Shionogi Pharma, Inc. Receives Marketing & Manufacturing Approval For Peramivir in Japan | January 13, 2010 | BioSpace - Breaking News |
| BioCryst's Partner Shionogi Receives Marketing & Manufacturing Approval For Peramivir in Japan | January 13, 2010 | Biotech News - PR Newswire |
| BioCryst and moksha8 Announce Approval for the Importation & Use of peramivir in Mexico | January 12, 2010 | Pharma News - PR Newswire |
| moksha8 and BioCryst Gain Approval for the Importation and Use of Peramivir in Mexico for the Treatment of H1N1 Influenza | January 12, 2010 | Biotech News - PR Newswire |
| Biocryst Pharmaceuticals Inks Deal with Two Company's to Market Influenza Drug; Names Merck Serono, Hikma Pharmaceuticals as New Partners | January 11, 2010 | BioSpace |
| Biocryst Pharmaceuticals Inks Deal with 2 Company's to Market Influenza Drug; Names Merck Serono, Hikma Pharmaceuticals as New Partners | January 11, 2010 | BioSpace |
| Merck KGaA, Hikma To Market BioCryst Drug | January 11, 2010 | Health News - Fox Business |
| BioCryst drug enters Korean approval process | January 08, 2010 | Health News - BizJournals.com |
| Biocryst Pharmaceuticals's Partner Green Cross Files for Peramivir Regulatory Approval in South Korea | January 08, 2010 | BioSpace - Breaking News |
| BioCryst's Partner Green Cross Files for Peramivir Regulatory Approval in South Korea | January 08, 2010 | Clinical Trials - PR Newswire |
| Biocryst Pharmaceuticals to Present at Healthcare Conference | January 06, 2010 | BioSpace - Breaking News |
| BioCryst to Present at J.P. Morgan Healthcare Conference | January 05, 2010 | Pharma News - PR Newswire |
| Former Glaxo CEO joins BioCryst board | December 09, 2009 | Health News - BizJournals.com |
| Former Glaxo CEO Charles Sanders joins BioCryst board | December 09, 2009 | Health News - BizJournals.com |
| BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors | December 09, 2009 | Pharma News - PR Newswire |
| Biocryst Pharmaceuticals Bull Blames Conspiracy for Stock's Fall: BioBuzz | November 24, 2009 | BioSpace |
